User-friendly Biotinylated Human Pd-l2/b7-dc Protein (pdl-hm402b) Series [NbmWRw5h]

User-friendly Biotinylated Human Pd-l2/b7-dc Protein (pdl-hm402b) Series [NbmWRw5h]

Introducing the User-friendly Biotinylated Human Pd-l2/b7-dc Protein (pdl-hm402b) Series [NbmWRw5h], a cutting-edge research tool designed for advanced molecular biology applications. This protein is a crucial component in understanding the complex interactions within the immune system, particularly in the context of cancer immunotherapy. With its high purity and exceptional quality, the PDL-HM402B is ideal for various experimental setups, including flow cytometry, immunoprecipitation, and ELISA.

• High Purity: Our protein is rigorously tested for purity, ensuring reliable and consistent results.
• Biotinylated: The biotin labeling enhances the protein's versatility in various detection methods.

The User-friendly Biotinylated Human Pd-l2/b7-dc Protein (pdl-hm402b) Series [NbmWRw5h] is produced through a state-of-the-art expression system, guaranteeing a high level of protein expression and functionality. Each batch undergoes strict quality control measures to ensure the highest standards of consistency and reliability. The protein is supplied in a lyophilized form, which not only preserves its stability but also makes it convenient for storage and shipping.

• Expression System: Engineered for optimal protein expression and functionality.
• Lyophilized Form: Easy to store and ship, with enhanced stability over time.

The User-friendly Biotinylated Human Pd-l2/b7-dc Protein (pdl-hm402b) Series [NbmWRw5h] is a valuable asset for researchers in the fields of immunology, oncology, and cellular biology. Its applications extend to the study of immune checkpoint inhibitors, tumor immunity, and the development of novel therapeutic strategies. Ideal for both academic and industrial research, this protein can be utilized in various experimental settings, providing researchers with the tools they need to advance their studies.

• Research Applications: Ideal for studying immune checkpoint inhibitors and tumor immunity.
• Target Audience: Researchers in immunology, oncology, and cellular biology.